Financial Year |
March 31 2023 |
Monetary Funds |
3,993,815,243.27 |
Held-for-trading Financial Assets |
200,000,000.00 |
Notes Receivable |
2,048,961,759.92 |
Accounts Receivable |
3,749,822,453.43 |
Advances to Suppliers |
379,786,072.94 |
Other Receivables |
77,829,003.89 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,781,724,117.08 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
54,021,109.40 |
Total Current Assets |
13,301,553,376.51 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
494,088,176.49 |
Investment Properties |
398,598,984.41 |
Fixed Assetes |
414,075,695.74 |
Under-construction Projects |
95,695,594.83 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
361,970,546.21 |
R&D expenses |
16,283,471.30 |
Goodwill |
685,676,016.95 |
Long-Term Deferred and Prepaid Expenses |
33,818,938.81 |
Deferred Income Tax Assets |
19,313,703.38 |
Other Non-Current Assets |
555,374,171.82 |
Sub-Total of Non-Current Assets |
3,187,704,446.07 |
Total Assets |
16,489,257,822.58 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
538,871,230.35 |
Accounts Payable |
1,095,243,514.70 |
Accounts Received In Advance |
2,940,757.49 |
Employee Compensation Payable |
539,957,953.54 |
Taxes Payable |
98,316,152.06 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
85,276,621.42 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
147,871,271.33 |
Other Current Liabilities |
338,510,739.03 |
Sub-Total of Current Liabilities |
4,061,991,301.60 |
Long-term Loans |
419,500,000.00 |
Bonds Payable |
1,332,724,881.51 |
Long-Term Accounts Payable |
800,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
77,468,056.50 |
Other Non-Current Liabilities |
115,000,000.00 |
Sub-Total of Non-Current Liabilities |
2,074,442,660.02 |
Total Liabilities |
6,136,433,961.62 |
Paid-In Capital(Or Share Stock) |
849,617,907.00 |
Capital Surplus |
649,356,428.72 |
Surplus Reserve |
139,508,432.28 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
8,460,213,380.51 |
Minority Stockholder's Interest |
68,415,222.43 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,284,408,638.53 |
Owner's Equity(Stockholder's Equity) |
10,352,823,860.96 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
16,489,257,822.58 |